7 Sickle Cell Disease Therapies to Watch Following Pfizer’s...

a adăugat un sunet Health

2025-09-01 17:11:43 -

7 Sickle Cell Disease Therapies to Watch Following Pfizer’s OXBRYTA Withdrawal

The removal of Pfizer’s Oxbryta (osivelotor) from the market has significantly reshaped the sickle cell disease treatment landscape, opening opportunities for novel therapies to gain ground. With multiple ongoing clinical trials of sickle cell disease‐modifying treatments underway as of October 2024, the pipeline remains both dynamic and expanding. Below, we highlight seven pivotal...

0 Commentarii 0 Distribuiri 74 Views 0 previzualizare